alendronate has been researched along with Diabetic Neuropathies in 2 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Diabetic Neuropathies: Peripheral, autonomic, and cranial nerve disorders that are associated with DIABETES MELLITUS. These conditions usually result from diabetic microvascular injury involving small blood vessels that supply nerves (VASA NERVORUM). Relatively common conditions which may be associated with diabetic neuropathy include third nerve palsy (see OCULOMOTOR NERVE DISEASES); MONONEUROPATHY; mononeuropathy multiplex; diabetic amyotrophy; a painful POLYNEUROPATHY; autonomic neuropathy; and thoracoabdominal neuropathy. (From Adams et al., Principles of Neurology, 6th ed, p1325)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pitocco, D | 2 |
| Ruotolo, V | 2 |
| Caputo, S | 2 |
| Mancini, L | 2 |
| Collina, CM | 1 |
| Manto, A | 2 |
| Caradonna, P | 2 |
| Ghirlanda, G | 2 |
| Collina, MC | 1 |
| Musella, T | 1 |
| Galli, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Treatment With DENOsumab of an Acute CHARCOT Foot in Patients With Diabetes. A Multicenter, Double-blind, Randomized, Placebo-controlled Trial.[NCT04547348] | Phase 3 | 38 participants (Anticipated) | Interventional | 2020-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for alendronate and Diabetic Neuropathies
| Article | Year |
|---|---|
Interaction between IGF-1, inflammation, and neuropathy in the pathogenesis of acute charcot neuroarthropathy: lessons from alendronate therapy and future perspectives of medical therapy.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Density Conservation Agents; Bone Resorpti | 2008 |
1 trial available for alendronate and Diabetic Neuropathies
| Article | Year |
|---|---|
Six-month treatment with alendronate in acute Charcot neuroarthropathy: a randomized controlled trial.
Topics: Acute Disease; Alendronate; Arthropathy, Neurogenic; Bone Resorption; Diabetic Neuropathies; Disabil | 2005 |